1. Home
  2. CF vs NBIX Comparison

CF vs NBIX Comparison

Compare CF & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CF Industries Holdings Inc.

CF

CF Industries Holdings Inc.

HOLD

Current Price

$119.70

Market Cap

18.7B

Sector

Industrials

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$154.23

Market Cap

15.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CF
NBIX
Founded
1946
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.7B
15.5B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
CF
NBIX
Price
$119.70
$154.23
Analyst Decision
Hold
Strong Buy
Analyst Count
14
22
Target Price
$118.93
$180.91
AVG Volume (30 Days)
2.0M
1.4M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.58%
N/A
EPS Growth
33.09
41.95
EPS
8.71
3.30
Revenue
$7,084,000,000.00
$161,626,000.00
Revenue This Year
$3.85
$24.73
Revenue Next Year
N/A
$13.14
P/E Ratio
$13.52
$46.82
Revenue Growth
19.34
977.51
52 Week Low
$75.42
$122.14
52 Week High
$141.96
$186.12

Technical Indicators

Market Signals
Indicator
CF
NBIX
Relative Strength Index (RSI) 52.42 37.64
Support Level $111.57 $153.96
Resistance Level $130.53 $161.29
Average True Range (ATR) 4.21 6.19
MACD -0.45 -1.86
Stochastic Oscillator 60.12 15.14

Price Performance

Historical Comparison
CF
NBIX

About CF CF Industries Holdings Inc.

CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making the company one of the lowest-cost nitrogen producers globally. It is also investing in carbon-free blue and green ammonia, which can be used as an alternative fuel to hydrogen or as a means to transport hydrogen.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: